New Therapy for Chronic Sciatica Receives FDA Fast Track Designation, First-in-Human Trial Evaluates Safety of Epidural Administration
Consano Bio’s platelet-derived multi-protein product C-1101 aims to simultaneously suppress inflammation and promote repair near damaged nerves; however, evidence of efficacy remains limited to the preclinical stage, and the ongoing 24-person trial will first address questions of safety.